Acquired von Willebrand Syndrome in a Child Following Berlin Heart EXCOR Pediatric Ventricular Assist Device Implantation

The development of acquired von Willebrand syndrome (AVWS) after placement of a pulsatile-flow left ventricular assist device (LVAD) is rare and only recently recognized. We report the case of a young infant who was diagnosed with ventricular assist device (VAD)-related AVWS following implantation of a Berlin Heart EXCOR Pediatric Ventricular Assist Device (Berlin Heart Inc., The Woodlands, Texas, USA) for treatment of severe heart failure. Despite significant bleeding, the patient was successfully managed with von Willebrand factor-containing concentrate until VAD explantation led to definitive resolution of the AVWS. This case demonstrates that the possibility of this diagnosis should be considered in pediatric patients when extensive, nonsurgical bleeding is encountered after pulsatile-flow VAD implantation.

[1]  A. Ganser,et al.  How I treat the acquired von Willebrand syndrome. , 2011, Blood.

[2]  P. V. van Genderen,et al.  Acquired von Willebrand Syndrome: Data from an International Registry , 2000, Thrombosis and Haemostasis.

[3]  Metzner,et al.  Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  R. Hoffmann,et al.  Collagen binding provides a sensitive screen for variant von Willebrand disease. , 2013, Clinical chemistry.

[5]  A. Ouattara,et al.  Acquired von Willebrand disease in a child with a ventricular assist device. , 2013, Journal of Thoracic and Cardiovascular Surgery.

[6]  A. Federici,et al.  Treatment of acquired von Willebrand syndrome in childhood. , 2013, Blood.

[7]  E. Blackstone,et al.  Berlin Heart EXCOR Pediatric Ventricular Assist Device for Bridge to Heart Transplantation in US Children , 2013, Circulation.

[8]  A. Ganser,et al.  Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study , 2008, Journal of thrombosis and haemostasis : JTH.

[9]  S. Schulman,et al.  Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease , 1999, Thrombosis and Haemostasis.

[10]  A. Amodeo,et al.  Neurological complications during pulsatile ventricular assistance with the Berlin Heart EXCOR in children: incidence and risk factors. , 2013, Artificial organs.

[11]  J. T. ten Cate,et al.  Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. , 1996, Blood.

[12]  M. Slaughter,et al.  Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device , 2010, Circulation. Heart failure.

[13]  Dong Chen,et al.  Comparative Analysis of von Willebrand Factor Profiles in Pulsatile and Continuous Left Ventricular Assist Device Recipients , 2010, ASAIO journal.

[14]  J. Heit,et al.  Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging. , 2010, Thrombosis research.

[15]  Dong Chen,et al.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. , 2010, The Annals of thoracic surgery.

[16]  R. Schneppenheim,et al.  Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis , 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  Christoph Benk,et al.  Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  T. Singh Prospective trial of a pediatric ventricular assist device. , 2012, The New England journal of medicine.

[19]  Anna L Meyer,et al.  Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  B. Yawn,et al.  von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1 , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  D. Cutler,et al.  The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story , 2013, Journal of thrombosis and haemostasis : JTH.